| Autor: |
Shemshedini T; Department of Gynecologic Oncology, Westchester Medical Center, 100 Woods Road, Valhalla, NY, 10595, USA. tshemshe@gmail.com., Pradhan TS; Department of Gynecologic Oncology, Westchester Medical Center, 100 Woods Road, Valhalla, NY, 10595, USA. pradhant@wcmc.com., Pua TL; Department of Gynecologic Oncology, Westchester Medical Center, 100 Woods Road, Valhalla, NY, 10595, USA. puat@wcmc.com., Tedjarati SS; Department of Gynecologic Oncology, Westchester Medical Center, 100 Woods Road, Valhalla, NY, 10595, USA. tedjaratis@wcmc.com. |
| Abstrakt: |
In the United States, the epidemic of obesity is readily apparent in women diagnosed with endometrial cancer, the most common gynecologic malignancy. Overall, the benefits of minimally invasive surgery and its oncologic outcomes are similar among laparoscopy and robotic approaches. However, in stratifying obese patients by BMI, more data is needed on morbidly obese patients and their candidacy for robotic surgery along with the technical challenges of staging procedures. Cost analysis studies targeted specifically to the obese and morbidly obese patient is needed to further justify efforts at promoting robotic surgery in this patient population. |
Full text from SpringerLink